Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study

Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study - Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014358

Enrollment

Registered

2014-06-23

Start date

2014-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory pneumothorax or malignant pleural effusion

Interventions

pleurodesis by intrapleural administration of 200ml of 50% glucose solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with pneumothorax or malignant pleural effusion 2.Written informed consent

Exclusion criteria

Exclusion criteria: 1.uncontrollable diabetes 2.unstable angina or myocardial infarction within one month 3.pregnancy 4.inappropriate patients for this study judged by the physicians

Design outcomes

Primary

Measure	Time frame
Effectiveness of pleurodesis with 50% glucose solution	—

Secondary

Measure	Time frame
1.Dyspnea and chest pain 2.Safety	—

Countries

Japan

Contacts

Public ContactYasuji Arimura

University of Miyazaki Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine

yasuji_arimura@med.miyazaki-u.ac.jp0985-85-2965

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026